Detection of SCN1A mutations in patients with severe myoclonic epilepsy in infancy by custom resequence array

Sugawara, Takayuki; Yoshida, Shuichi; Onodera, Naoko; Wada, Kazumaru; Hirose, Shinichi; Kaneko, Sunao

doi:10.21307/joepi-2015-0001

Abstract

Introduction

Very few epilepsy phenotypes have been associated with causative genes; nevertheless, it is becoming possible, for some epilepsy phenotypes, to predict the most efficacious anti-epileptic drugs for patients based on their genetic makeup. The development of individualized medicine based on genetic information and the genetic diagnosis of epilepsy are expected to greatly improve the diagnosis and treatment of epilepsy. Here, we developed a DNA array (resequencing array) for the genetic diagnosis of epilepsies in which 14 epilepsy – related genes (SCN1A, SCN1B, CHRNA4, CHRNA7, CHRNB2, GABRA1, GABRD, GABRG2, CACNB4, CLCN2, KCNQ2, KCNQ3, CACNA1A, and CACNA1H) have been mounted.

Aim

The aim of the present study is to evaluate the performance of our custom array in detecting the SCN1A mutations in patients with severe myoclonic epilepsy in infancy.

Material and methods

We compared mutation data generated by DNA array sequencing of DNA samples from patients with severe myoclonic epilepsy in infancy to the data generated by capillary sequencing.

Results

Heterozygosity was detected in 44 of 48 patients (92%). We successfully identified epilepsy mutations, and the results of DNA array analyses were largely consistent with the results of capillary sequencing analysis.

Conclusion

These findings indicate that this DNA array is likely to be a useful tool in clinical settings.

References

Blumenfeld H., Klein J.P., Schridde U., Vestal M., Rice T., Khera D.S. et al.:Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia, 2008, 49: 400–409.10.1111/j.1528-1167.2007.01458.x314318218070091
Search in Google Scholar Back to article
Claes L., Del-Favero J., Ceulemans B., Lagae L., Van Broeckhoven C., De Jonghe P.:De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am. J. Hum. Genet., 2001, 68: 1327–1332.10.1086/320609122611911359211
Search in Google Scholar Back to article
Claes L.R., Ceulemans B., Audenaert D., Deprez L., Jansen A., Hasaerts D. et al.:De novo KCNQ2 mutations in patients with benign neonatal seizures. Neurology, 2004, 63: 2155–2158.10.1212/01.WNL.0000145629.94338.8915596769
Search in Google Scholar Back to article
Dravet C., Bureau M., Guerrini R., Giraud N., Roger J.:Severe myoclonic epilepsy in infants. In: J. Roger, M. Bureau, C. Dravet, F.E. Dreifuss, A. Perret, P. Wolf (Eds), Epileptic syndromes in infancy, childhood and adolescence. 2nd ed., John Libbey & Company Ltd, London 1992, 75–88.
Search in Google Scholar Back to article
Fujiwara T., Sugawara T., Mazaki-Miyazaki E., Takahashi Y., Fukushima K., Watanabe M. et al.:Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. Brain, 2003, 126: 531–546.10.1093/brain/awg05312566275
Search in Google Scholar Back to article
Fukuma G., Oguni H., Shirasaka Y., Watanabe K., Miyajima T., Yasumoto S. et al.:Mutations of neuronal voltagegated Na+ channel alpha 1 subunit gene SCN1A in core severe myoclonic epilepsy in infancy (SMEI) and in borderline SMEI (SMEB). Epilepsia, 2004, 45: 140–148.10.1111/j.0013-9580.2004.15103.x14738421
Search in Google Scholar Back to article
Gennaro E., Veggiotti P., Malacarne M., Madia F., Cecconi M., Cardinali S. et al.:Familial severe myoclonic epilepsy of infancy: truncation of Nav1.1 and genetic heterogeneity. Epileptic Disord., 2003, 5: 21–25.
Search in Google Scholar Back to article
Hacia J.G.:Resequencing and mutational analysis using oligonucleotide microarrays. Nat. Genet., 1999, 21: 42–47.10.1038/44699915500
Search in Google Scholar Back to article
Kaneko S,, Yoshida S., Kanai K., Yasui-Furukori N., Iwasa H.:Development of individualized medicine for epilepsy based on genetic information. Expert Rev. Clin. Pharmacol., 2008, 1: 661–681.10.1586/17512433.1.5.66124422737
Search in Google Scholar Back to article
Kearney J.A., Wiste A.K., Stephani U., Trudeau M.M., Siegel A., Ramachandran Nair R. et al.:Recurrent de novo mutations of SCN1A in severe myoclonic epilepsy of infancy. Pediatr. Neurol., 2006, 34: 116–120.10.1016/j.pediatrneurol.2005.07.00916458823
Search in Google Scholar Back to article
Kwan P., Brodie M.J.:Early identification of refractory epilepsy. Engl. J. Med., 2000, 342: 314–319.10.1056/NEJM20000203342050310660394
Search in Google Scholar Back to article
Madia F., Striano P., Gennaro E., Malacarne M., Paravidino R., Biancheri R. et al.:Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancy. Neurology, 2006, 10: 1230–1235.10.1212/01.wnl.0000238513.70878.5417030758
Search in Google Scholar Back to article
Mulley J.C., Nelson P., Guerrero S., Dibbens L., Iona X., McMahon J.M. et al.:A new molecular mechanism for severe myoclonic epilepsy of infancy: exonic deletions in SCN1A. Neurology, 2006, 67: 1094–1095.10.1212/01.wnl.0000237322.04338.2b
Search in Google Scholar Back to article
Nabbout R., Gennaro E., Dalla Bernardina B., Dulac O., Madia F., Bertini E. et al.:Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology, 2003, 24: 1961–1967.10.1212/01.WNL.0000069463.41870.2F
Search in Google Scholar Back to article
Nasir M., Olga V., Anthony M., Munir.:Exploring the genomic basis of pharmacoresistance in epilepsy: an integrative analysis of large-scale gene expression profiling studies on brain tissue from epilepsy surgery. Hum. Mol. Genet., 2011, 20: 4381–4394.10.1093/hmg/ddr365
Search in Google Scholar Back to article
Ohmori I., Ouchida M., Ohtsuka Y., Oka E., Shimizu K.:Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy. Biochem. Biophys. Res. Commun., 2002, 295: 17–23.10.1016/S0006-291X(02)00617-4
Search in Google Scholar Back to article
Ottman R., Hirose S., Jain S., Lerche H., Lopes-Cendes I., Noebels J.L. et al.:Genetic testing in the epilepsies-report of the ILAE Genetics Commission. Epilepsia, 2010, 51: 655–670. Reid C.A., Berkovic S.F., Petrou S.:Mechanisms of human inherited epilepsies. Prog. Neurobiol., 2009, 87: 41–57.
Search in Google Scholar Back to article
Saitoh M., Shinohara M., Hoshino H., Kubota M., Amemiya K., Takanashi J.L. et al.:Mutations of the SCN1A gene in acute encephalopathy. Epilepsia, 2012, 53: 558–564.10.1111/j.1528-1167.2011.03402.x22309220
Search in Google Scholar Back to article
Shi L., Reid L.H., Jones W.D., Shippy R., Warrington J.A., Baker S.C. et al.:The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol., 2006, 24: 1151–1161.
Search in Google Scholar Back to article
Steinlein O.K., Magnusson A., Stoodt J., Bertrand S., Weiland S., Berkovic S.F. et al.:An Insertion Mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Human. Mol. Genet., 1997, 6: 943–947. Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R. et al.:A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet., 1995, 11: 201–203.
Search in Google Scholar Back to article
Sugawara T., Tsurubuchi Y., Agarwala K.L., Ito M., Fukuma G., Mazaki-Miyazaki E. et al.:A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc. Natl. Acad. Sci. USA, 2001, 98: 6384–6389.10.1073/pnas.1110650983347711371648
Search in Google Scholar Back to article
Suls A., Claeys K.G., Goossens D., Harding B., Van Luijk R., Scheers S. et al.:Microdeletion involving the SCN1A gene may be common in SCN1A-mutation-negative SMEI patients. Hum. Mutat., 2006, 27: 914–920.10.1002/humu.2035016865694
Search in Google Scholar Back to article
Wang J.W., Kurahashi H., Ishii A., Kojima T., Ohfu M., Inoue T. et al.:Microchromosomal deletions involving SCN1A and adjacent genes in severe myoclonic epilepsy in infancy. Epilepsia, 2008, 49: 1528–1534.10.1111/j.1528-1167.2008.01609.x18479393
Search in Google Scholar Back to article
Zhu G., Okada M., Yoshida S., Ueno S., Mori F., Takahara T. et al.:Rats harboring S284L Chrna4 mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and exhibit the nocturnal frontal lobe epilepsy phenotype. J. Neurosci., 2008, 28: 12465–12476.10.1523/JNEUROSCI.2961-08.2008667172119020039
Search in Google Scholar Back to article